Sanofi (SNY) Current Leases (2019 - 2025)

Sanofi has disclosed Current Leases across 7 years of filings, most recently posting $316.6 million for Q4 2025.

• Current Leases for Q4 2025 came in at $316.6 million, up 13.52% year-over-year; the trailing twelve-month figure through Dec 2025 was $316.6 million (up 13.52% YoY), and the FY2025 annual result was $316.6 million, up 13.52% from the prior year.
• Current Leases came in at $316.6 million for Q4 2025 at Sanofi, up from $285.3 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $316.6 million in Q4 2025 to a low of $246.5 million in Q2 2022.
• The 5-year median for Current Leases is $290.6 million (2023), against an average of $288.7 million.
• Across the five-year window, Current Leases decreased 17.13% in 2022 and climbed 13.52% in 2025, its largest moves.
• Sanofi's Current Leases stood at $307.7 million in 2021, then slipped by 8.16% to $282.6 million in 2022, then advanced by 4.7% to $295.9 million in 2023, then retreated by 5.74% to $278.9 million in 2024, then climbed by 13.52% to $316.6 million in 2025.
• The last three Current Leases figures came in at $316.6 million (Q4 2025), $285.3 million (Q2 2025), and $278.9 million (Q4 2024), per Business Quant data.